Charles Schwab’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-302,463
| Closed | -$10.4M | – | 3439 |
|
|
2020
Q3 | $10.4M | Buy |
302,463
+12,344
| +4% | +$425K | ﹤0.01% | 1665 |
|
|
2020
Q2 | $4.85M | Buy |
290,119
+24,830
| +9% | +$415K | ﹤0.01% | 2046 |
|
|
2020
Q1 | $3.83M | Buy |
265,289
+3,471
| +1% | +$50.1K | ﹤0.01% | 1961 |
|
|
2019
Q4 | $8.76M | Buy |
261,818
+8,464
| +3% | +$283K | ﹤0.01% | 1721 |
|
|
2019
Q3 | $5.31M | Buy |
253,354
+17,553
| +7% | +$368K | ﹤0.01% | 1927 |
|
|
2019
Q2 | $4.91M | Buy |
235,801
+7,878
| +3% | +$164K | ﹤0.01% | 1981 |
|
|
2019
Q1 | $5.1M | Buy |
227,923
+10,019
| +5% | +$224K | ﹤0.01% | 1974 |
|
|
2018
Q4 | $5.21M | Buy |
217,904
+2,327
| +1% | +$55.7K | ﹤0.01% | 1885 |
|
|
2018
Q3 | $5.88M | Buy |
215,577
+8,322
| +4% | +$227K | ﹤0.01% | 1957 |
|
|
2018
Q2 | $5.57M | Buy |
207,255
+23,678
| +13% | +$637K | ﹤0.01% | 1938 |
|
|
2018
Q1 | $5.84M | Buy |
183,577
+45,129
| +33% | +$1.44M | ﹤0.01% | 1855 |
|
|
2017
Q4 | $5.24M | Buy |
138,448
+27,868
| +25% | +$1.05M | ﹤0.01% | 1896 |
|
|
2017
Q3 | $2.74M | Buy |
110,580
+4,891
| +5% | +$121K | ﹤0.01% | 2158 |
|
|
2017
Q2 | $2.17M | Buy |
105,689
+18,632
| +21% | +$383K | ﹤0.01% | 2196 |
|
|
2017
Q1 | $1.89M | Buy |
87,057
+4,788
| +6% | +$104K | ﹤0.01% | 2220 |
|
|
2016
Q4 | $1.68M | Buy |
82,269
+4,312
| +6% | +$88.2K | ﹤0.01% | 2247 |
|
|
2016
Q3 | $1.17M | Buy |
77,957
+25,963
| +50% | +$390K | ﹤0.01% | 2365 |
|
|
2016
Q2 | $563K | Buy |
51,994
+25,278
| +95% | +$274K | ﹤0.01% | 2548 |
|
|
2016
Q1 | $363K | Buy |
26,716
+459
| +2% | +$6.24K | ﹤0.01% | 2708 |
|
|
2015
Q4 | $485K | Buy |
26,257
+16,185
| +161% | +$299K | ﹤0.01% | 2655 |
|
|
2015
Q3 | $256K | Buy |
+10,072
| New | +$256K | ﹤0.01% | 2884 |
|